The Treatment Episode Data Set (TEDS) records the type of service to which clients are admitted for treatment. The major categories are broadly defined as ambulatory, rehabilitation/residential, and detoxification. For this report, admissions for which medication-assisted opioid therapy (i.e., therapy using methadone or buprenorphine) was planned have been categorized as a separate service type. It is important to note that percentages in charts, narrative lists, and percentage distributions in tables may not add to 100 percent due to rounding. The complete list of types of services detailed in this report include:

• Ambulatory (excluding medication-assisted opioid therapy)
  • Outpatient—Ambulatory treatment services including individual, family, and/or group services; these may include pharmacological therapies.
  • Intensive outpatient—As a minimum, the client must receive treatment lasting two or more hours per day for three or more days per week.
• Detoxification (excluding medication-assisted opioid therapy)
  • Free-standing residential—24-hour per day services in a non-hospital setting providing for safe withdrawal and transition to ongoing treatment.
  • Hospital inpatient—24-hour per day medical acute care services in a hospital setting for detoxification of persons with severe medical complications associated with withdrawal.
  • Ambulatory—Outpatient treatment services providing for safe withdrawal in an ambulatory setting (pharmacological or non-pharmacological).
• Rehabilitation/residential (excluding medication-assisted opioid therapy)
  • Short-term (30 days or fewer)—Typically, 30 days or less of non-acute care in a setting with treatment services for alcohol and other drug abuse and dependency.
  • Long-term (more than 30 days)—Typically, more than 30 days of non-acute care in a setting with treatment services for alcohol and other drug abuse and dependency; this may include transitional living arrangements such as halfway houses.
  • Hospital—24-hour per day medical care in a hospital facility in conjunction with treatment services for alcohol and other drug abuse and dependency.
• Medication-assisted opioid therapy
  • Outpatient—Includes outpatient and intensive outpatient therapy (see above).
  • Detoxification—Includes free-standing residential detoxification, hospital detoxification, and ambulatory detoxification (see above).
  • Residential—Includes short-term, long-term, and hospital inpatient therapy (see above).

Table 4.1b. The type of service received was associated with primary substance of abuse.

• Ambulatory treatment accounted for 55 percent of all admissions—44 percent in outpatient treatment and 12 percent in intensive outpatient treatment. Admissions for marijuana and methamphetamine/amphetamines were more likely to receive ambulatory services than were all admissions (85 percent of marijuana admissions and 63 percent of methamphetamine/amphetamine admissions vs. 55 percent of all admissions).
  
• Detoxification services accounted for 22 percent of all admissions—18 percent in free-standing residential, 3 percent in hospital inpatient, and 1 percent in ambulatory. Admissions for tranquilizers, alcohol, and opiates were more likely to receive a detoxification service than were all admissions (39 percent of tranquilizer admissions, 29 percent of alcohol admissions, and 28 percent of opiate admissions vs. 22 percent of all admissions).
  
• Rehabilitation/residential treatment accounted for 17 percent of all admissions—9 percent in short-term, 7 percent in long-term, and less than 1 percent in hospital inpatient. Admissions for cocaine, methamphetamine/amphetamines, and tranquilizers were more likely to receive rehabilitation/residential services than were all admissions (27 percent of cocaine admissions, 26 percent of methamphetamine/amphetamine admissions, and 21 percent of tranquilizer admissions vs. 17 percent of all admissions).
  
• Medication-assisted opioid therapy accounted for 6 percent of all admissions—5 percent in outpatient, 1 percent in detoxification, and less than 1 percent in residential. Medication-assisted opioid therapy was planned for about one-quarter (23 percent) of admissions for opiates.

Table 4.3a. The type of service received was associated with the treatment referral source.

• Admissions receiving an ambulatory service were more likely than all admissions to have been referred through the criminal justice/DUI source (49 percent of outpatient admissions and 44 percent of intensive outpatient admissions vs. 34 percent of all admissions).
  
• Admissions receiving a detoxification service were more likely to be self- or individual referrals (74 percent of hospital inpatient admissions, 56 percent of free-standing residential admissions, and 50 percent of ambulatory admissions vs. 36 percent of all admissions).
  
• Admissions receiving short-term or long-term rehabilitation/residential treatment were more likely to have been referred by a substance abuse care provider (25 percent of short-term admissions and 19 percent of long-term admissions vs. 9 percent of all admissions).
  
• Admissions receiving outpatient or detoxification medication-assisted opioid therapy were more likely to be self- or individual referrals (81 percent of detoxification admissions and 76 percent of outpatient admissions vs. 36 percent of all admissions).

TO TABLES

To Table of Contents